Skip to content

RNTX RNTX Other operating expenses

Other operating expenses at other companies

CTO
Citius Oncology, Inc.CTOR
$29.95M+301%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
$11.44M-27.5%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$99.07M-4.6%
Tenet Healthcare logo
Tenet HealthcareTHC
$1.12B+2.9%
Insmed logo
InsmedINSM
-0.1%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$76.67M+42.9%

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's other operating expenses?
RNTX (RNTX) reported other operating expenses of $5.23M in Q1 2026.
How has RNTX's other operating expenses changed year-over-year?
RNTX's other operating expenses decreased by 6.8% year-over-year, from $5.61M to $5.23M.
What is the long-term trend for RNTX's other operating expenses?
Over 4 years (2021 to 2025), RNTX's other operating expenses has grown at a 17.5% compound annual growth rate (CAGR), from $26.61M to $50.63M.
What does other operating expenses mean?
Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.